sciclone pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : sciclone pharmaceuticals

SCLN 11.15

0.0%

Oct 20 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Skywatcher who wrote (1106)	6/28/2003 9:17:01 PM
From: JEB	of 1137

The latest and greatest choices on the market are: Pegasys (made by Roche) which for some reason has slightly less side effects but seems to be just a remix version of Pegintron (interferon-A2b). Pegintron (made by Schering Plough) which has several side effects but most of those are temporary and range from inconvenience to treatable severe irritations. Both are married to cocktail therapy in conjuction with either Copegus (Roche's ribavirin pills) or Rebetol (Schering Plough's ribavirin pills). The ribavirin therapy has many more side effects which are undesirable (ask the SARS patients they'll tell you since the injectable form of ribavirin called rebetron was tested on them). Zadaxin is aiming (IMO) to eliminate the need for the ribavirin therapy as a replacement or at the very least to be added as a second adjuvant in the cocktail therapy.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next